Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Shulman Joseph sold 45,921 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 18, 2026 · Filed Nov 20, 2026
On Nov 18, 2026, Shulman Joseph (Chief Technical Officer) sold 45,921 Rhythm Pharmaceuticals, Inc. shares at US$119.90 for US$5.51M under a trading plan, leaving 10,461 shares. Filed Nov 20, 2026 (Form 4).
- Sold
- 45,921 shares
- Price
- US$119.90
- Value
- US$5.51M
- Holding after
- 10,461 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Technical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | Option exercise | 1,961 | US$6.80 | 17,876 | Direct |
| Nov 18, 2026 | Common Stock | Option exercise | 4,188 | US$27.35 | 22,064 | Direct |
| Nov 18, 2026 | Common Stock | Option exercise | 24,944 | US$49.23 | 47,008 | Direct |
| Nov 18, 2026 | Common Stock | Option exercise | 9,374 | US$56.69 | 56,382 | Direct |
| Nov 18, 2026 | Common Stock | Sale | 45,921 | US$119.90 | 10,461 | Direct |
Source
Download original · View original at SEC
Related
- Rhythm Pharmaceuticals, Inc.
- Shulman Joseph
- Rhythm Pharmaceuticals, Inc. shareholders
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Jean Christophe · Nov 18, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026